首页 | 本学科首页   官方微博 | 高级检索  
     

静脉输注免疫球蛋白治疗特发性血小板减少性紫癜
引用本文:宋艳秋,姜振宇,李舜华,李薇,高素君,时亚香,王春艳,易永林,刘淑英,聂荣国,陈维金. 静脉输注免疫球蛋白治疗特发性血小板减少性紫癜[J]. 中国生物制品学杂志, 1995, 8(3): 126-128
作者姓名:宋艳秋  姜振宇  李舜华  李薇  高素君  时亚香  王春艳  易永林  刘淑英  聂荣国  陈维金
摘    要:大剂量静脉输注免疫球蛋白(IVIg)治疗特发性血小板减少性紫癜(ITP)20例,15天之内100%病例血小板升至5×1010/L以上.70%病例血小板升至1×1011/L以上,与激素治疗组相比,具有血小板升速快,幅度大的优点。经激素治疗无效的患者,用大剂量IVIg治疗亦有效,使用中未发现毒副作用。

关 键 词:ITP  IVIg

Treatment of Idiopathic Thrombocytopenic Purpura with Intravenous Ig (IVIg)
Song Yanqiu et al. Treatment of Idiopathic Thrombocytopenic Purpura with Intravenous Ig (IVIg)[J]. Chinese Journal of Bilogicals, 1995, 8(3): 126-128
Authors:Song Yanqiu et al
Abstract:20 cases of idiopathic thrombocytopenic purpura (ITP) were treated with in-travenous Ig (IVIg) in high dosage. Within 15 days, the platelet amounts of all case increasedup to >5 × 1010/L, and 70% of them increased up to>1×1011/L. Compared with thosetreated with hormone, the platelet amounts of the patients treated with IVIg increased at ahigher speed and to a higher extent. The IVIg was demonstrated to be effective in the caseswho failed to respond to hormone, and no side effect was found during the administration.
Keywords:ITP IVIg  
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号